首页 / 资料库 / 文献详情

Progress of the treatment of diabetic nephropathy

Wenrui LiuLin Liao

2017中国综合临床Neuroscience被引 1

出版方页面 →

摘要

The treatment of diabetic nephropathy(DN) currently extent to control the occurrence and development of it and delay renal failure on a certain stage.However, the effect is not satisfactory.Some traditional hypoglycemic, antihypertensive, lipid and anticoagulant drugs in DN patients with renal protective effect.And some have been in clinical use of drugs such as vitamin D, aldose reductase inhibitors, tripterygium wilfordii glycoside has proved to have the effect of the slow progress in DN, could be used more widely.For new drugs, such as renin inhibitors, phosphodiesterase inhibitors and methyl bartholomew sauron, while partialy was confirmed in a role in the treatment of DN, but before the clinical promotion, its effectiveness and safety still need further study to verify. Key words: Diabetes; Diabetic nephropathy; Drug treatment

引用本文(GB/T 7714)

Wenrui Liu, Lin Liao. Progress of the treatment of diabetic nephropathy[J]. 中国综合临床, 2017.

引文网络

参考文献与被引分析加载中…

DOI:https://doi.org/10.3760/cma.j.issn.1008-6315.2017.06.018

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。